skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi group now that W results are out and the stock has settled down I am still confused they had another blow out quarter but the stock has generally sold off (except for several days of upward momentum. Then on Friday a really bad day (down 13% + on the week ) is the market saying that the arrival of a vaccine is the catalyst for the stock to sell off? seems awful early to be forecasting that consumers are going to leave this on line supplier because the vaccine is a game changer - appreciate your views and recommendation buy sell or hold and why ?
Read Answer Asked by Terence on November 16, 2020
Q: No question on CoStar (CSGP) in the database.

Great Cash Flows, low Cap Ex. Grew Reneues and EPS roughly at 10x in 10 year with only ~2x share count increase. Something good is happening here. However, on P/E basis, it is really expensive.

With Gross Margin at 80% and 20% Net Margin I don't understand why ROE is so low (<10%).

Balance sheet is fine with very little debt. Digitizing conservative industry (real-estate), which appears to have good long term growth opportunities.

Is that a US version of Altus Group? What do you think of the Name?
Read Answer Asked by Jennifer on November 16, 2020
Q: Thank you so much for your recommendation on WYNN, GC, BKNG, LUV. They went up a lot.
I still have some cash that I would like to invest.
Are there any stocks that are still undervalued even after recent vaccine news? Or should I just wait for them to dip again? Thanks!
Read Answer Asked by Yongwei on November 16, 2020
Q: Hi - Need some insight. I have had SWK for awhile and it has done well, but I am not sure how much more room there is for it to grow. I am thinking of selling and using the money on ATVI. Only concern is that ATVI might be a "Covid" stock whose value will decline with a vaccine. What do you think about these moves?
Read Answer Asked by Patrick on November 13, 2020
Q: Hi,

I hold a 2.5% position in NVDA after selling half to lock in my original costs. I'd like to pick up another high growth chip maker/developer/fabricator, and the listed companies are on my watch list. Ideally the company would have a great balance sheet (net cash), a pipeline of great products and great opportunity for growth - no dividend needed. Can you endorse one or two and/or recommend something not on the list?

Cam
Read Answer Asked by Cameron on November 13, 2020
Q: Hi again,

I asked a question about SAFE the other day. Thanks for your answer there.

I was actually asking because of the I didn't know whether the new public offering represented a positive or a negative sign. Can you comment on that?

Also, they talk about offering these shares at $61 until Nov 13 (tomorrow!) which is lower than the market price. I am a shareholder and would be interested in buying at this price, but am not sure if it's available to me or how I would acquire the shares.

Feel free to make this a public question if you think the information would be useful to other members. If you could reply in time for me to buy the shares (if I'm able), I'd appreciate it but don't expect it.

Read Answer Asked by Kevin on November 13, 2020
Q: I am looking to add more healthcare to my portfolio - thinking about adding Pfizer plus an ETF. Given the recent vaccine news I am surprised that the price of PFE has not really soared. Can you shed some light on this? Do you feel PFE has upside growth potential - is it a good buy at the current prices? Patrick
Read Answer Asked by Patrick on November 12, 2020
Q: Can I get your thoughts on PSNL please, it's gotten some attention now that ARK has disclosed they own 10.1%. Is this company good enough for a starter position?
Read Answer Asked by dan on November 12, 2020
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!